Related Experiment Video
Updated: Jan 9, 2026

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice
Published on: May 17, 2024
Cerebral Small Vessel Disease: Bystander or Culprit?
Emma L King1, Hla Hla Aye2, Eluzai Abe Hakim3
1Emergency Department, University Hospitals Dorset NHS Foundation Trust, Bournemouth, GBR.
Insights
Cerebral small vessel disease (SVD) is a major cause of dementia. This case study confirms a NOTCH3 gene mutation in a patient with SVD, highlighting the importance of genetic testing for cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).
Area of Science:
- Neurology
- Genetics
- Vascular Medicine
Background:
- Cerebral small vessel disease (SVD) accounts for approximately 45% of dementias, causing significant disability.
- Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common monogenic stroke cause, linked to NOTCH3 gene mutations.
- NOTCH3 mutations lead to protein aggregation in cerebral vessels, impairing blood flow.
Abstract:
Cerebral small vessel disease (SVD) contributes to about 45% of dementias and causes substantial cognitive, psychiatric, and physical disability. The most common form of monogenic strokes is cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), which is caused by mutations in the NOTCH3 gene. This leads to cerebrovascular NOTCH3 protein aggregation and compromises cerebral blood flow. We present the case of a 69-year-old female patient presenting with dysarthria, a past medical history of migraines, and a family history of early-onset stroke. She was treated at a large district general hospital. Non-contrast computed tomography (CT) brain showed changes in keeping with small vessel ischaemic change. Subsequent magnetic resonance imaging (MRI) revealed an acute right frontal lobe infarct with extensive high signal intensity changes. Involvement of the temporal lobes suggested CADASIL as a possible differential diagnosis. The genetic testing confirmed a heterozygous pathogenic NOTCH3 variant. This case highlights the importance of testing for CADASIL in patients with extensive SVD changes coupled with a history of stroke at an early age or family history of strokes. Informed written consent was obtained from the patient to publish her clinical information anonymously.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
The Blood-brain Barrier

